Resources on how to help others and yourself as a startup founder during these troubling times for the tech scene
A crisis on this scale can reorder society in dramatic ways, for better or worse. Here are 34 big thinkers’ predictions for what’s to come. Politico Magazine surveyed more than 30 smart, macro thinkers this week, and they have some news for you: Buckle in. This could be bigger.
The Entreprenation Community has the experience and expertise to address in a short time-lapse (24 h) new problems and generate solution prototypes based on 24-Hour Challenge format developed and refined during the 7 editions held over the last 4 years.
The time is now. Join the fight against Covid-19. Humankind can and will take back control. We are working on medical devices, to have a fast and easy solution that can be reproduced and assembled locally worldwide. #projectopenair
The coronavirus outbreak is first and foremost a human tragedy, affecting hundreds of thousands of people. It is also having a growing impact on the global economy. This article is intended to provide business leaders with a perspective on the evolving situation and implications for their companies. The outbreak is moving quickly, and some of the perspectives in this article may fall rapidly out of date. This article reflects our perspective as of March 16, 2020. This article will be updated regularly as the outbreak evolves.
To cushion the blow to people’s livelihoods and the economy, the Commission has adopted a comprehensive economic response to the outbreak applied the full flexibility of the EU fiscal rules, has revised its State Aid rules and set up a EUR 37 billion Coronavirus Response Investment Initiative to provide liquidity to small businesses and the health care sector.
The COVID-19 Therapeutics Accelerator is designed to bring together resources and expertise to lower the financial and technical risk for academia, biotech, and pharmaceutical companies, while ensuring that new treatments are accessible and affordable to people in low-resource settings. The Accelerator will identify, assess, develop, and scale-up new and repurposed drugs and biologics, with an immediate focus on COVID-19 and a long-range plan to fight viral pathogens through work on broad-spectrum antivirals or immunotherapies, according to the Gates Foundation.